Enovis ENOV
NYSE ENOV
$18.60 -0.43 (-2.26%)
As of: Sep 10, 2026 · 12:40 PM EDT

Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026)

Enovis' (ENOV) quarterly Net Equity Issued and Repurchased came in at $380000.0 in Q3 2026, down 51.78% year-over-year from $788000.0 in Q3 2025, and down 39.49% quarter-over-quarter from $628000.0 in Q2 2026.

Analysis

Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

Enovis (ENOV) has reported Net Equity Issued and Repurchased for 16 consecutive years, with $380000.0 the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 51.78% year-over-year to $380000.0 in Q3 2026; TTM through Jul 2026 was $1.2 million, a 34.45% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 29.67% from the prior year.
  • Net Equity Issued and Repurchased was $380000.0 for Q3 2026 at Enovis, down from $628000.0 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $3.3 million in Q4 2022 and troughed at $104000.0 in Q3 2023.
  • A 5-year average of $693529.4 and a median of $438000.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Across the five-year window, Net Equity Issued and Repurchased plunged 99.83% in 2022 and soared 263.46% in 2024, its largest moves.
  • Over 5 years, Net Equity Issued and Repurchased stood at $3.3 million in 2022, then sank by 91.26% to $287000.0 in 2023, then advanced by 11.15% to $319000.0 in 2024, then sank by 40.75% to $189000.0 in 2025, then jumped by 101.06% to $380000.0 in 2026.
  • The last three Net Equity Issued and Repurchased figures came in at $380000.0 (Q3 2026), $628000.0 (Q2 2026), and $189000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn -
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn 20.00 Mn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn -
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn -
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn -
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn -
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn 380,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 380,000.00
Apr 3, 2026 628,000.00
Oct 3, 2025 189,000.00
Jul 4, 2025 788,000.00
Apr 4, 2025 341,000.00
Dec 31, 2024 319,000.00
Sep 27, 2024 378,000.00
Jun 28, 2024 306,000.00
Mar 29, 2024 871,000.00
Dec 31, 2023 287,000.00
Sep 29, 2023 104,000.00
Jun 30, 2023 947,000.00
Mar 31, 2023 438,000.00
Dec 31, 2022 3.28 Mn
Sep 30, 2022 803,000.00
Jul 1, 2022 528,000.00
Apr 1, 2022 1.20 Mn
Dec 31, 2021 7.00 Mn
Oct 1, 2021 8.18 Mn
Jul 2, 2021 13.37 Mn